x

Coronavirus

BioNTech Says It Plans 2 Billion Vaccine Doses

Germany’s BioNTech, which developed the first COVID-19 vaccination on the market with American partner Pfizer, says it expects to produce 2 billion doses in 2021 with ramped-up manufacturing.

Company CEO and co-founder Ugur Sahin says with three manufacturing sites in the United States and three in Europe operating or coming online soon, it expects to approximately double the number of doses committed for this fiscal year.

The company said in a presentation Monday to the annual J.P. Morgan Healthcare Conference that it is also looking to expand the people able to receive its vaccine to include pregnant women and children, among others.

As of Jan 10, the company says it has already shipped 32.9 million doses of its vaccine. The vaccine was 95% effective in trials.

The company’s vaccine currently has to be stored at extremely cold temperatures, making delivery to remote areas difficult. But the company says it’s working on a more stable version.

RELATED

BEIJING (AP) — Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, adding evidence to the theory that the virus originated from animals, not from a lab, international experts say.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.